Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Zimmer Anticipates Lower-Than-Expected Pricing Cuts In Japan

This article was originally published in The Gray Sheet

Executive Summary

Zimmer predicts that upcoming Japanese pricing cuts will be less severe than expected, echoing a similar forecast by Stryker

You may also be interested in...

Stryker Plans To Quell Japanese Pricing Cut Storm With R&D Investments

Stryker will rely on developing its product pipeline in 2006 to withstand large price cuts from Japan in 2007, according to CEO Steve MacMillan

Chilly Japanese Medical Device Climate Draws Fire From Hill, Industry

Japan's regulatory and reimbursement systems came under fire this week from lawmakers on Capitol Hill and attendees of AdvaMed's international conference in Arlington, Va

Amneal Eyes Avastin And Praises $120m Biosimilar Development Savings

Amneal is close to a filed pipeline of three biosimilar products in the US, while furthering ambitions in the complex generics and 505(b)(2) space, management told the virtual J.P. Morgan Healthcare Conference.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts